Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / ORD SHS
-
Total 13F shares
-
13,970,280
-
Share change
-
+648,260
-
Total reported value
-
$417,694,000
-
Put/Call ratio
-
5.6%
-
Price per share
-
$29.90
-
Number of holders
-
73
-
Value change
-
+$20,701,974
-
Number of buys
-
43
-
Number of sells
-
28
Institutional Holders of NEURODERM LTD - ORD SHS as of Q2 2017
As of 30 Jun 2017,
NEURODERM LTD - ORD SHS was held by
73 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,970,280 shares.
The largest 10 holders included
SCOPIA CAPITAL MANAGEMENT LP, MENORA MIVTACHIM HOLDINGS LTD., ADAGE CAPITAL PARTNERS GP, L.L.C., Viking Global Investors LP, FRANKLIN RESOURCES INC, BAKER BROS. ADVISORS LP, Redmile Group, LLC, RHENMAN & PARTNERS ASSET MANAGEMENT AB, WELLS FARGO & COMPANY/MN, and SENZAR ASSET MANAGEMENT, LLC.
This page lists
73
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.